Gatti, M., Virgili, G., Viale, P., Pea, F. (2024). Is intrathecal or intraventricular therapy with polymyxins or aminoglycosides still needed for improving the outcome of post-neurosurgical extensively/multi drug-resistant (XDR/MDR) Gram-negative bacteria (-GNB) related meningitis/ventriculitis in the current era of novel beta-lactams beta-lactam/beta-lactamase inhibitor combinations?. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 10.1016/j.ijantimicag.2024.107177, 1-4 [10.1016/j.ijantimicag.2024.107177].
Is intrathecal or intraventricular therapy with polymyxins or aminoglycosides still needed for improving the outcome of post-neurosurgical extensively/multi drug-resistant (XDR/MDR) Gram-negative bacteria (-GNB) related meningitis/ventriculitis in the current era of novel beta-lactams beta-lactam/beta-lactamase inhibitor combinations?
Gatti, Milo;Virgili, Giulio;Viale, Pierluigi;Pea, Federico
2024
File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
